Skip to main content
. 2012 Feb 15;22(1):63–75. doi: 10.11613/bm.2012.007

Table 3.

Disorders and mechanisms involved in hyperuricemia.

Disorder Mechanism
Gout
  • Primary

  • Secondary
    • - Usage of specific drugs or intoxication (19)
    • -Renal failure (20)
    • -Familial juvenile hyperuricemic nephropathy (90)
    • - Autosomal-dominant medullar cystic kidney disease (91)
Alcohol reduced renal urate excretion in lactic acidemia; Several antihypertensives interfere with renal tubular ion transport; Immunosuppressants (i.e. cyclosporine), reduce renal clearance of serum urate.
Impaired kidney function.
Mutation of gene for uromodulin.
Mutations of genes for polycystins 1 (PC1) and 2 (PC2).

Cardiovascular disorders (8,64,69)
  • Coronary heart disease

  • Congestive heart failure

  • Stroke

  • Peripheral artery disease

Endothelial dysfunction, oxidative stress, inhibition of NO-synthesis.

Hypertension (8,64,69,72,89) Endothelial disfunction (60);
Activation of renin-angiotensin system (55);
Impaired glomerular filtration rate (63);
Inhibition of NO-synthesis.

Chronic kidney disease (8) Increased monocyte chemoattractant protein (MCP-1) in cultured vascular smooth muscle cells and human proximal tubular epithelial cells.

Metabolic syndrome and its components (79)
  • Insulin resistance

  • Obesity

  • Hyperlipidemia

  • Hypertension

Increased intracellular adenosine (uric acid precursor a derivative of higher AMP concentrations due to increased synthesis of fatty acid-acyl-CoA in peripheral tissues.

Therapy of cancer Purine derivatives